AdvaMed Publish Date: November 3, 2022 Read the Full Article>> Challenges of AI in MedTech In the medical device space, powerful insights from real-world data can seem ‘just out of reach’. Capturing patient characteristics and outcomes, at scale and with consistency over time, is challenging outside of clinical trials. Personalization – bridging the gap between[…]
Listen to OM1’s podcast episode on the Medical Affairs Professional Society (MAPS) “Elevate” podcast series. Dr. Carl Marci is discussing the use of Real-World Data and Real-World Evidence to understand and possibly intercede in treatment-resistant depression and why it is especially difficult to develop treatments against resistant depression using the traditional structure of R&D-led clinical[…]
Built In Publish Date: September 9, 2022 Read the Full Article >> About the company: Founded in 2015, OM1 developed its data cloud to provide advanced technological tools for researchers and support their quest to find new ways of understanding and treating chronic conditions. Yaning Zhang, Sr. Software Engineer, shared how OM1 turns data into insight:[…]
HealthEconomics.com – A Scientist.com Company Publish Date: August 26th, 2022 Multiple sclerosis (MS) is a chronic illness in which the body’s immune system attacks myelin, the substance that surrounds and protects the nerve fibers of the central nervous system. The result is a disabling disease that causes damage to the brain and spinal cord[…]
Inside Precision Medicine Published Online: August 18, 2022 Read the Full Article >> Artificial intelligence (AI) has promised major breakthroughs in clinical development success. While the hype has sometimes seemed overblown, AI is starting to deliver on those promises through real-world impact. AI is not a silver bullet for all challenges, but in specific applications,[…]
